Perhaps the most clinically relevant work presented in this issue is a study by
Garland et al., 2017
that links regional clinical data from the Calgary MS clinic with a Canadian discharge
abstract database. Their investigation suggests that hospitalization in general is
associated with subsequent worsening of MS disability. For each in-patient admission,
there is a 0.23 increase in average EDSS which equates to 2.5 years of time-related
disease progression in that dataset. In the period after hospitalization, the subsequent
rate of disability progression does not change. This is a major finding that should
lead to optimization of general health in patients with chronic neurological diseases
such as MS, and prompt care providers to maximize prevention of health changes that
lead to unplanned hospital admission and the associated deconditioning, infection,
and stress.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Multiple Sclerosis and Related DisordersAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Tumefactive demyelinating lesions: a comprehensive review.Mult. Scler. Relat. Disord. 2017; 14: 72-79
- Using endogenous saccades to characterize fatigue in multiple sclerosis.Mult. Scler. Relat. Disord. 2017; 14: 16-22
- Hospitalization is associated with subsequent disability in multiple sclerosis.Mult. Scler. Relat. Disord. 2017; 14: 23-28
- Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis.Mult. Scler. Relat. Disord. 2017; 14: 1-3
- Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin.Mult. Scler. Relat. Disord. 2017; 14: 12-15
- Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients.Mult. Scler. Relat. Disord. 2017; 14: 51-55
- Video head impulse test can detect brainstem dysfunction in multiple sclerosis.Mult. Scler. Relat. Disord. 2017; 14: 68-71
- Vitamin D and multiple sclerosis: an update.Mult. Scler. Relat. Disord. 2017; 14: 35-45
- Terminalia chebula attenuates quinolinate-induced oxidative PC12 and OLN-93 cell death.Mult. Scler. Relat. Disord. 2017; 14: 60-67
- Infectious mononucleosis and multiple sclerosis – Updated review on associated risk.Mult. Scler. Relat. Disord. 2017; 14: 56-59
- Neuromyelitis optica presenting with horner syndrome: a case report and review of literature.Mult. Scler. Relat. Disord. 2017; 14: 32-34
- Soluble CD40 ligand derived from serum is not correlated with early MS.Mult. Scler. Relat. Disord. 2017; 14: 29-31
Article info
Publication history
Published online: April 20, 2017
Identification
Copyright
© 2017 Published by Elsevier B.V.
